New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Insulet Corporation
PODD
Shape
US Flag

NASDAQ

16B

Medical - Devices

Next Earning date - 07 Nov 2024

16B

Medical - Devices

Next Earning date - 07 Nov 2024

234.84USD
Shape-1.76 ( -0.74%)
favorite-chart

Relative Strenght

25
favorite-chart

Volume Buzz

-33%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated October 24, 2024
1W -0.74 % 1M -1.66 % 3M 23.03 % 1Y 68.18 %

Key Metrics

Shape
  • Market Cap

    16.47B


  • Shares Outstanding

    70.12M


  • Share in Float

    69.66M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    234.84


  • Average Volume

    700246


  • Beta

    1.212


  • Range

    128.68-243.98


  • Industry

    Medical - Devices


  • Website

    https://www.insulet.com


  • Sector

    Healthcare


Fundamentals

Shape

69.27x

P/E Ratio

8.79x

P/S Ratio

16.48x

P/B Ratio

1.4

Debt/Equity

21.1%

Net Margin

$5.5

EPS

How PODD compares to sector?

P/E Ratio

Relative Strength

Shape

PODD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape388%

2025-Revenue

$3.88

Shape44%

2025-EPS

$190M

Shape158%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

OTR Global

downgrade

Previous: Not converted

2024-06-10

Now: Mixed

Wolfe Research

upgrade

Previous: Not converted

2024-05-07

Now: Outperform

Pivotal Research

upgrade

Previous: Not converted

2023-12-21

Now: Outperform

Morgan Stanley

upgrade

Previous: Equal-Weight

2023-12-04

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+150%

0.45
vs 0.18

Q4.22

arrow
arrow

+31%

0.55
vs 0.42

Q1.23

arrow
arrow

-42%

0.23
vs 0.4

Q2.23

arrow
arrow

+733%

0.38
vs -0.06

Q3.23

arrow
arrow

+58%

0.71
vs 0.45

Q4.23

arrow
arrow

+155%

1.4
vs 0.55

Q1.24

arrow
arrow

+217%

0.73
vs 0.23

Q2.24

arrow
arrow

+45%

0.55
vs 0.38

Q3.24

arrow
arrow

+10%

0.78
vs 0.71

Q4.24

arrow
arrow

-28%

1.01
vs 1.4

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+24%

340.8M  vs 275.6M

Q4.22

arrow
arrow

+20%

369.7M  vs 307.7M

Q1.23

arrow
arrow

+21%

358.1M  vs 295.4M

Q2.23

arrow
arrow

+32%

396.5M  vs 299.4M

Q3.23

arrow
arrow

+27%

432.7M  vs 340.8M

Q4.23

arrow
arrow

+38%

509.8M  vs 369.7M

Q1.24

arrow
arrow

+23%

441.7M  vs 358.1M

Q2.24

arrow
arrow

+23%

488.5M  vs 396.5M

Q3.24

arrow
arrow

+20%

518.8M  vs 432.7M

Q4.24

arrow
arrow

+11%

567.5M  vs 509.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.08

Q4.22

arrow
arrow

+4%

0.04
vs -0.01

Q1.23

arrow
arrow

+5%

0.05
vs 0.04

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+9%

0.09
vs 0.05

Q4.23

arrow
arrow

+14%

0.14
vs 0.09

Q1.24

arrow
arrow

+7%

0.07
vs 0.14

Q2.24

arrow
arrow

+19%

0.19
vs 0.07

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

469

469
vs 449

4%

Q4.22

arrow
arrow

535

535
vs 469

14%

Q1.23

arrow
arrow

597

597
vs 535

12%

Q2.23

arrow
arrow

593

593
vs 597

-1%

Q3.23

arrow
arrow

555

555
vs 593

-6%

Q4.23

arrow
arrow

612

612
vs 555

10%

Q1.24

arrow
arrow

586

586
vs 612

-4%

Q2.24

arrow
arrow

617

617
vs 586

5%

Earnings Growth

Latest News